125 related articles for article (PubMed ID: 24945588)
1. Response to pain management among patients with active cancer, no evidence of disease, or chronic nonmalignant pain in an outpatient palliative care clinic.
Jennings C; Cassel B; Fletcher D; Wang A; Archer KJ; Skoro N; Yanni L; Del Fabbro E
J Palliat Med; 2014 Sep; 17(9):990-4. PubMed ID: 24945588
[TBL] [Abstract][Full Text] [Related]
2. Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain.
Yennurajalingam S; Kang JH; Hui D; Kang DH; Kim SH; Bruera E
J Pain Symptom Manage; 2012 Sep; 44(3):340-50. PubMed ID: 22699092
[TBL] [Abstract][Full Text] [Related]
3. Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation--A preliminary report.
Yennurajalingam S; Chisholm G; Palla SL; Holmes H; Reuben JM; Bruera E
Palliat Support Care; 2015 Apr; 13(2):135-43. PubMed ID: 24182896
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
6. Chronic pain in the outpatient palliative care clinic.
Merlin JS; Childers J; Arnold RM
Am J Hosp Palliat Care; 2013 Mar; 30(2):197-203. PubMed ID: 22556285
[TBL] [Abstract][Full Text] [Related]
7. Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?
Harris K; Li K; Flynn C; Chow E
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):523-7. PubMed ID: 17566723
[TBL] [Abstract][Full Text] [Related]
8. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic.
Yennurajalingam S; Urbauer DL; Casper KL; Reyes-Gibby CC; Chacko R; Poulter V; Bruera E
J Pain Symptom Manage; 2011 Jan; 41(1):49-56. PubMed ID: 20739141
[TBL] [Abstract][Full Text] [Related]
9. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
[TBL] [Abstract][Full Text] [Related]
10. Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index.
Mitera G; Zeiadin N; Kirou-Mauro A; DeAngelis C; Wong J; Sanjeevan T; Sinclair E; Danjoux C; Barnes E; Tsao M; Sahgal A; Chow E
J Pain Symptom Manage; 2010 Feb; 39(2):259-67. PubMed ID: 20152589
[TBL] [Abstract][Full Text] [Related]
11. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial.
Israel FJ; Parker G; Charles M; Reymond L
J Pain Symptom Manage; 2010 Mar; 39(3):548-54. PubMed ID: 20083373
[TBL] [Abstract][Full Text] [Related]
12. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
[TBL] [Abstract][Full Text] [Related]
13. The role of clinical hypnosis and self-hypnosis to relief pain and anxiety in severe chronic diseases in palliative care: a 2-year long-term follow-up of treatment in a nonrandomized clinical trial.
Brugnoli MP; Pesce G; Pasin E; Basile MF; Tamburin S; Polati E
Ann Palliat Med; 2018 Jan; 7(1):17-31. PubMed ID: 29307207
[TBL] [Abstract][Full Text] [Related]
14. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.
Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S
Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
Dale O; Piribauer M; Kaasa S; Moksnes K; Knobel H; Klepstad P
J Pain Symptom Manage; 2009 Jan; 37(1):68-76. PubMed ID: 18504090
[TBL] [Abstract][Full Text] [Related]
16. The routine use of the Edmonton Classification System for Cancer Pain in an outpatient supportive care center.
Arthur J; Yennurajalingam S; Nguyen L; Tanco K; Chisholm G; Hui D; Bruera E
Palliat Support Care; 2015 Oct; 13(5):1185-92. PubMed ID: 25311930
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of opioid rotation in the control of cancer pain: the ROTODOL study.
González-Barboteo J; Alentorn XG; Manuel FA; Candel VA; Eito MA; Sánchez-Magro I; Álvarez MN; Martín FJ; Porta-Sales J
J Opioid Manag; 2014; 10(6):395-403. PubMed ID: 25531957
[TBL] [Abstract][Full Text] [Related]
18. Normal-release oral morphine starting dose in cancer patients with pain.
Ripamonti CI; Campa T; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; De Conno F;
Clin J Pain; 2009 Jun; 25(5):386-90. PubMed ID: 19454871
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a liaison clinic for patients with intractable chronic pain.
Tetsunaga T; Tetsunaga T; Nishie H; Ozaki T
J Orthop Sci; 2015 Sep; 20(5):907-13. PubMed ID: 26166383
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
